What is it about?
This review summarizes the neurotransmitter and neuropeptide alterations in the brainstem and hippocampus in major depression. This review suggests a multimodal antidepressant pharmacotherapy.
Featured Image
Why is it important?
The interaction between presynaptic inhibitory and postsynaptic neurotransmitters is of importance and is included in the description of neural networks
Perspectives
A mulitmodal pharmacotherapy in major depression can enhance the antidepressant effect. GABAB antagonists can be combined with selective noradrenaline reuptake inhibitors.
Dr Felix-Martin Werner
Euro Akademie Pößneck
Read the Original
This page is a summary of: Classical Neurotransmitters and Neuropeptides Involved in Major Depression in a Multi-neurotransmitter System: A Focus on Antidepressant Drugs, Current Medicinal Chemistry, November 2013, Bentham Science Publishers,
DOI: 10.2174/09298673113206660280.
You can read the full text:
Contributors
The following have contributed to this page
